Worldwide causes of blindness mapped

Article

Major geographical differences exist worldwide in cases of cataracts and macular degeneration, according to the largest-ever analysis of worldwide vision impairment and blindness, which was recently published in The Lancet Global Health journal.

Major geographical differences exist worldwide in cases of cataracts and macular degeneration, according to the largest-ever analysis of worldwide vision impairment and blindness, which was recently published in The Lancet Global Health journal.

Researchers of this study, led by Dr Rupert Bourne, BSc (Hons), FRCOphth, MD, of the Vision and Eye Research Unit at Anglia Ruskin University, Cambridge, UK, analysed a large range of both published and unpublished data on vision impairment and blindness to produce figures for 1990 and 2010 of the main causes of blindness and vision impairment worldwide and by geographical region.

Some of the important findings of this study, funded by the Bill & Melinda Gates Foundation, Fight for Sight, the Fred Hollows Foundation and the Brien Holden Vision Institute, include the following:

  • The number of people affected by blindness caused by cataracts decreased between 1990 and 2010, from 12.3 million to 10.8 million.
  • The number of people affected by moderate and severe vision impairment fell from 44 million to 35.2 million.
  • The causes of blindness differed substantially by region, with the prevalence of cataracts being lowest and macular degeneration being greatest in the highest-income regions.
  • In 2010, the proportion of blindness caused by cataracts ranged from 40% in South and Southeast Asia and Oceania.
  • The proportion of blindness caused by macular degeneration was higher in regions with older, higher-income populations including Europe and North America. In these areas, > 15% of blindness was caused by macular degeneration, with the proportion much lower in regions such as South Asia (2.6%).
  • In all regions, the proportion of blindness and moderate and severe vision impairment caused by cataract and macular degeneration was higher in women than in men.
  • In 2010, cataract or uncorrected refractive error led to 54% of blindness cases and 71% of moderate and severe vision impairment cases.
  • Of the 31.8 million people who were blind in 1990, 68% had preventable or treatable causes. By 2010, this proportion had decreased to 65% of the 32.4 million who were blind.

"Being able to study in detail the changes in cause-specific prevalence of blindness and vision impairment is important for the setting of priorities, development of policies and for planning," said Dr Bourne. "Additionally, our data will be a useful tool to help mobilize eye care services from governments, donors and civil society," he concluded.

For the full text of this article, click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.